Capital Asset Advisory Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Other funds holding HZNP
ACA
PC
Capital Asset Advisory Services's HZNP Position: Q1 2021 in Review
Capital Asset Advisory Services sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2021, closing a stake of 200 shares — an estimated $15K sold.
Capital Asset Advisory Services first reported a position in HZNP in Q4 2020 and held it in 1 quarter. The position peaked at $15K in Q4 2020. 516 funds tracked by Wall St. Rank hold HZNP as of Q1 2021.
- Capital Asset Advisory Services reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2021 after selling out during the quarter.
- Capital Asset Advisory Services sold 200 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2021, an estimated $15K.
- Capital Asset Advisory Services first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 1 quarter.
- Capital Asset Advisory Services's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $15K in Q4 2020.
- 516 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2021.
Based on Capital Asset Advisory Services's 13F filing for Q1 2021, filed 13 May 2021.